C
Cellectar Biosciences, Inc. (CLRB)
NCM – Real Time Price. Currency in USD
2.70
-0.20 (-6.90%)
At close: Mar 27, 2026, 4:00 PM EDT
2.70
0.00 (0.00%)
After-hours: Mar 27, 2026, 7:12 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
2.70
-0.20 (-6.90%)
At close: Mar 27, 2026, 4:00 PM EDT
2.70
0.00 (0.00%)
After-hours: Mar 27, 2026, 7:12 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.96 | 6.05 | 10 | |
| Quick ratio | 2.96 | 5.63 | 10 | |
| Debt to Equity | 0.04 | 0.30 | 9.0 | |
| Debt to Assets | 0.03 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -148K | -192K | -292K | -214K | -214K |
| Operating Income | -29M | -39M | -52M | -23M | -23M |
| Net Income | -32M | -43M | -45M | -22M | -22M |
| EBITDA | -29M | -39M | -51M | -23M | -23M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 55.12 | 5.5 |
| Next quarter | N/A | 69.03 | 5.5 |
| Current year | N/A | 52.34 | 5.5 |
| Next year | N/A | 23.49 | 5.5 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -19.15 | 146.1 | -1.74 | 5.5 |
| Y/Y | 999 | -124.8 | 130.95 | 60.36 | 7.8 |
| 3y average | 999 | 4.13 | 53.72 | -7.51 | 6.3 |
| 5y average | 999 | -15.83 | 42.08 | -19.36 | 5.5 |
| Weighted average score | 6.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $13.2M significantly exceed its total debt $409.6K, ensuring strong financial flexibility
Total current assets $14.0M exceed Total current liabilities $4.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$4.4M limits the company's ability to reinvest or pay down debt